Benefits of near-universal vaccination and treatment access to manage COVID-19 burden in the United States
Abstract Background As we continue the fourth year of the COVID-19 epidemic, SARS-CoV-2 infections still cause high morbidity and mortality in the United States. During 2020–2022, COVID-19 was one of the leading causes of death in the United States and by far the leading cause among infectious disea...
Main Authors: | Fuhan Yang, Thu Nguyen-Anh Tran, Emily Howerton, Maciej F. Boni, Joseph L. Servadio |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12916-023-03025-z |
Similar Items
-
People and Data: solving planetary challenges together
by: Chiara Vanalli, et al.
Published: (2024-02-01) -
Características clínico-terapéuticas y factores de riesgo de mortalidad de los pacientes ingresados por infección por SARS-CoV-2 a lo largo de 6 ondas epidémicas
by: Beatriz Isidoro Fernández, et al.
Published: (2024-07-01) -
The Epidemiological Situation of Influenza in the World and Russia in the Season 2014 – 2015
by: L. S. Karpova, et al.
Published: (2015-08-01) -
Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts
by: Thu Nguyen-Anh Tran, et al.
Published: (2021-07-01) -
Impact of Quarantine and Vaccination Policies on Viral Load
by: Dimitrios Koumatzidis, et al.
Published: (2022-12-01)